login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
CHINOOK THERAPEUTICS INC (KDNY) Stock News
NASDAQ:KDNY -
US16961L1061
-
Common Stock
40.39
USD
+0.09 (+0.22%)
Last: 8/10/2023, 8:00:03 PM
40.32
USD
-0.07 (-0.17%)
After Hours:
8/10/2023, 8:00:03 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
KDNY Latest News, Press Relases and Analysis
All
Press Releases
2 years ago - By: Bragar Eagel & Squire
- Mentions:
JKS
CMA
IART
Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm
2 years ago - By: Benzinga
- Mentions:
NUVL
DKNG
PTRA
XPEV
...
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
2 years ago - By: Bragar Eagel & Squire
- Mentions:
JKS
IART
CMA
Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm
2 years ago - By: Benzinga
Expert Ratings for Chinook Therapeutics
2 years ago - By: The Motley Fool
- Mentions:
VERA
2 Surging Healthcare Stocks With More Fuel in the Tank
2 years ago - By: Bragar Eagel & Squire
- Mentions:
JKS
IART
CMA
Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm
2 years ago - By: Chinook Therapeutics, Inc.
Chinook Therapeutics Announces First Patient Enrolled in Pivotal Phase 3 BEYOND Study of Zigakibart (BION-1301) for Patients with IgA Nephropathy
2 years ago - By: Bragar Eagel & Squire
- Mentions:
IART
DLO
CMA
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm
2 years ago - By: Bragar Eagel & Squire
- Mentions:
CMA
AAP
EPAM
Bragar Eagel & Squire, P.C. Is Investigating Chinook, Comerica, Advance Auto Parts, and EPAM and Encourages Investors to Contact the Firm
2 years ago - By: Kahn Swick & Foti, LLC
CHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook Therapeutics, Inc. - KDNY
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY
2 years ago - By: Bragar Eagel & Squire
- Mentions:
CMA
AAP
EPAM
Bragar Eagel & Squire, P.C. Is Investigating Chinook, Comerica, Advance Auto Parts, and EPAM and Encourages Investors to Contact the Firm
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY
2 years ago - By: Bragar Eagel & Squire
- Mentions:
IART
DLO
CMA
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm
2 years ago - By: Bragar Eagel & Squire
- Mentions:
IART
DLO
CMA
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm
2 years ago - By: Investor's Business Daily
- Mentions:
NVS
ABBV
TVTX
Meet Chinook Therapeutics, The Company Novartis Is Spending $3.5 Billion To Acquire
2 years ago - By: Bragar Eagel & Squire
- Mentions:
AAP
CMA
DLO
Bragar Eagel & Squire, P.C. Is Investigating Chinook, DLocal, Comerica, and Advanced Auto Parts and Encourages Investors to Contact the Firm
2 years ago - By: Bragar Eagel & Squire
- Mentions:
BOWL
IART
DLO
Bragar Eagel & Squire, P.C. Is Investigating Bowlero, Integra, Chinook, and DLocal and Encourages Investors to Contact the Firm
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY
2 years ago - By: The Motley Fool
- Mentions:
VERA
NVS
Why Shares of Vera Therapeutics Jumped Tuesday
2 years ago - By: Bragar Eagel & Squire
- Mentions:
IART
PHAT
AKU
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, Phathom, and Akumin and Encourages Investors to Contact the Firm
2 years ago - By: Chinook Therapeutics, Inc.
Chinook Therapeutics Presents Data from CHK-336 Phase 1 Trial in Healthy Volunteers and New Insights into the Role of Failed Repair in Chronic Kidney Disease at the 60th European Renal Association (ERA) Congress
2 years ago - By: Investor's Business Daily
- Mentions:
LEN
ORCL
ADBE
UNH
...
Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review
2 years ago - By: Pomerantz LLP
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY
2 years ago - By: Brodsky & Smith LLC
- Mentions:
NEX
GHL
MFG
FRG
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NexTier Oilfield Solutions Inc. (NYSE – NEX), Chinook Therapeutics, Inc. (Nasdaq – KDNY), Franchise Group, Inc. (Nasdaq – FRG), Greenhill & Co., Inc. (NYSE – GHL)
2 years ago - By: Bragar Eagel & Squire
- Mentions:
IART
DZSI
Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, and DZS and Encourages Investors to Contact the Firm
2 years ago - By: Kahn Swick & Foti, LLC
CHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook Therapeutics, Inc. - KDNY
Please enable JavaScript to continue using this application.